Direct-Abdominal chemo trial offers hope for tough cancer cases
NCT ID NCT06269978
Summary
This early-stage study is testing whether delivering two common chemotherapy drugs directly into the abdominal cavity is safe and effective for patients with colorectal cancer that has spread only to the abdominal lining. Researchers will enroll 24 patients to find the right dose and monitor side effects. The goal is to see if this targeted approach can better control cancer in this specific area.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV COLORECTAL CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Contact Phone: •••-•••-••••
-
UT Southwestern/Simmons Cancer Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.